Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 37 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 9512204

    Humanized pertussis antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  2. US 9512401

    B and T lymphocyte attenuator marker for use in adoptive T-cell therapy

    The Board of Regents of the University of Texas System · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  3. US 9504658

    Stabilized HME composition with small drug particles

    The Board of Regents of the University of Texas System · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  4. US 9504701

    Methods for treating viral infections using hydrogen sulfide donors

    The Board of Regents of the University of Texas System · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  5. US 9504742

    Compositions for stimulation of mammalian innate immune resistance to pathogens

    The Board of Regents of the University of Texas System · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  6. US 9499595

    Development of influenza A antivirals

    The Board of Regents of the University of Texas System · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  7. US 9502711

    Fabrication of biscrolled fiber using carbon nanotube sheet

    The Board of Regents of the University of Texas System · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  8. US 9499588

    Flaviviruses expressing the prM, E, and NS1 proteins of other flaviviruses and uses thereof

    The Board of Regents of the University of Texas System · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  9. US 9492477

    Compositions comprising citrate and applications thereof

    The Board of Regents of the University of Texas System · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  10. US 9486456

    Treatment of esophageal motility disorder using sepiapterin, tetrahydrobiopterin and derivatives thereof

    The Board of Regents of the University of Texas System · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  11. US 9481692

    Heterocyclic modulators of HIF activity for treatment of disease

    The Board of Regents of the University of Texas System · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted
  12. US 9481877

    Engineered primate L-methioninase for therapeutic purposes

    The Board of Regents of the University of Texas System · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted
  13. US 9474730

    Methods and compositions for use with K-ras mediated disorders

    The Board of Regents of the University of Texas System · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted
  14. US 9469878

    Methods of treating cancer comprising targeting NQO1

    The Board of Regents of the University of Texas System · Granted Oct 18, 2016 · Expires Oct 13, 2036

    granted
  15. US 9463254

    Molecular design toward dual-modality probes for radioisotope-based imaging (PET or SPECT) and MRI

    The Board of Regents of the University of Texas System · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  16. US 9457002

    Antimicrobial compositions comprising glyceryl nitrates

    The Board of Regents of the University of Texas System · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted
  17. US 9458095

    Oligo-benzamide compounds and their use in treating cancers

    The Board of Regents of the University of Texas System · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted
  18. US 9452182

    Collateral gene inactivation biomarkers and targets for cancer therapy

    The Board of Regents of the University of Texas System · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted
  19. US 9447047

    Inhibitors of protein phosphatase-1 and uses thereof

    The Board of Regents of the University of Texas System · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted
  20. US 9446022

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted
  21. US 9446042

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted
  22. US 9439976

    Compositions and methods for using cathepsin E cleavable substrates

    The Board of Regents of the University of Texas System · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  23. US 9428749

    Control of whole body energy homeostasis by microRNA regulation

    The Board of Regents of the University of Texas System · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  24. US 9422318

    Epoxyeicosatrienoic acid analogs and methods of making and using the same

    The Board of Regents of the University of Texas System · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted